HOSPITAL UNIVERSITARIO RUBER
Departamento
Wellcome Trust Sanger Institute
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de Wellcome Trust Sanger Institute (2)
2017
-
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
Oncogene, Vol. 36, Núm. 19, pp. 2737-2749
-
The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
npj Breast Cancer, Vol. 3, Núm. 1